These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24250378)

  • 1. Formulation and evaluation of a novel matrix-type orally disintegrating Ibuprofen tablet.
    Tayebi H; Mortazavi SA
    Iran J Pharm Res; 2011; 10(3):469-79. PubMed ID: 24250378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and Taste Masking of Ranitidine Orally Disintegrating Tablet.
    Hesari Z; Shafiee A; Hooshfar S; Mobarra N; Mortazavi SA
    Iran J Pharm Res; 2016; 15(4):677-686. PubMed ID: 28243264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet.
    Aslani A; Beigi M
    Int J Prev Med; 2016; 7():120. PubMed ID: 27857833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS; Ming LC; Uddin ABMH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation Optimization and Assessment of Dexamethasone Orally Disintegrating Tablets Using Box-Behnken Design.
    Soroush H; Ghorbani-Bidkorbeh F; Mortazavi SA; Mehramizi A
    Iran J Pharm Res; 2018; 17(4):1150-1163. PubMed ID: 30568675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests.
    Momeni M; Afkanpour M; Rakhshani S; Mehrabian A; Tabesh H
    BMC Med Inform Decis Mak; 2024 Mar; 24(1):88. PubMed ID: 38539201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
    Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate, cetirizine hydrochloride in combined pharmaceutical dosage form: a new era in novel drug delivery for pediatrics and geriatrics.
    Sharma D; Singh G; Kumar D; Singh M
    J Drug Deliv; 2015; 2015():640529. PubMed ID: 25810924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Formulation and Physicochemical Evaluation of Dimenhydrinate Orally Disintegrating Tablets.
    Aslani A; Ghasemi A; Karbasizadeh Esfahani S
    Galen Med J; 2018; 7():e936. PubMed ID: 34466419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized furosemide taste masked orally disintegrating tablets.
    Ibrahim MA; Abou El Ela AESF
    Saudi Pharm J; 2017 Nov; 25(7):1055-1062. PubMed ID: 29158715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
    Devireddy SR; Gonugunta CS; Veerareddy PR
    PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
    Sheshala R; Khan N; Chitneni M; Darwis Y
    Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
    Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
    Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.